/Investor DB

DEFTA Partners — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

DiA Imaging Analysisdia-analysis.comAug 2021Acquired

AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.

Co-investorsAgate Medical Investments LPICON - Israel Collaboration NetworkMindset VentureConnecticut InnovationsIsrael Innovation AuthorityOutlier Ventures+3 more

Endogenaendogena.comSeries A · Jan 2021 · $8M

Endogena Therapeutics develops endogenous regenerative medicines aimed at treating degenerative diseases, with a program focused on retinal conditions such as those causing blindness.

BiotechMedical DevicesZürich, CH

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.